Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00091962 · ClinicalTrials.gov registry record · NA
Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 453
- Enrollment target
NCT00091962: Completed NA study, sponsored by University of Pittsburgh.
NCT00091962 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 453 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00091962, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 453 participants
- Enrollment target
Study Summary
The purpose of this study is to treat depression in patients who have undergone coronary artery bypass graft (CABG).
Primary Outcome
The 36-item Medical Outcomes Study Form (v.2) Mental Component Scale (SF-36 MCS). Range 0-100; Population norm is 50 with standard deviation of 10. Higher scores are better. Ware J, Kosinski M, Keller S. SF-36 Physical and Mental Health Summary Scales: A User's Manual. 2nd ed. Boston, MA: New England Medical Center; 1994.
Interventions
- OTHER Usual Care
- DRUG Pharmacotherapy
- BEHAVIORAL Psychoeducation; Treatment recommendations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 453 participants |
| Start Date | 2003-08 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00091962 record still lists
NCT00091962 is an interventional study that assigns participants to a tested intervention. The registered 453 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT00091962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00091962 about?
NCT00091962 is a clinical study titled "Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery". The purpose of this study is to treat depression in patients who have undergone coronary artery bypass graft (CABG).
What is the current status of trial NCT00091962?
This trial is currently completed. It is a NA study. The enrollment target is 453 participants. The study started on 2003-08. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00091962?
The interventions under investigation include: Usual Care (OTHER), Pharmacotherapy (DRUG), Psychoeducation; Treatment recommendations (BEHAVIORAL).
Who is sponsoring clinical trial NCT00091962?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00091962's enrollment target sits among peer trials
453 225th of 2000 higher than 1,776 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT05655936 · 454 participants · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia